Videos

Combining two checkpoint blockades can be very efficacious in treating metastatic melanoma, but the benefits come with increased risk of adverse events, too.

Managing immune-related adverse events is different from managing the effects of chemotherapy.

The recent approval of ibrutinib plus obinutuzumab is a major advancement in the chronic lymphocytic leukemia space.

Registered pharmacist Jamie Fritz, RPh, Oral Pharmacy Manager, Compass Oncology, describes the vital role that oral oncology nurses play in cancer care.

Howard Cohen, RPh, MS, FASHP, director of oncology pharmacy services, Smilow Cancer Center, Yale New Haven Health, discusses the challenges of cancer treatment from a pharmacy perspective.

Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center in Covington, Louisiana, shares some barriers to adherence to oral oncolytics that patients may face.

As part of an ambitious plan to transform the culture at Vidant Health and improve the experience of patients and team members alike, Oehlert helped reframe the organization’s goals to consider kindness and compassion as part of strategic excellence.

Tiki Barber, former NFL running back and radio host, explains how he feels about oncology nurses, who helped his mother through her breast cancer experience.

Nurses can take part in turning the tide against the disease.

Ascertaining family history and promoting screening are key.

John Marshall, MD, explains that health care providers need to retool their thinking when young people present with GI complaints, and be open to the possibility that these could indicate colon cancer.

Nurses can help coach and push patients and their physicians along to do the steps that are needed to get good screening, says John Marshall, MD.

In just over 5 years, the growth and development in the field of breast cancer have been astronomical. Julie Nangia, MD, Assistant Professor of Medicine, Baylor College of Medicine, discusses the recent explosion of knowledge about non-BRCA genes, and the significant progress in therapies targeted to BRCA mutation carriers.

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses the work ahead in the ovarian cancer field.

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses recent exciting developments in the ovarian cancer field.

Jim Kelly, NFL Hall of Famer, discusses how nurses inspire him.

Jason Luke, MD, assistant professor at the University of Chicago Medicine, discusses what he hopes the future of advanced melanoma treatment will look like.

Comprehensive geriatric oncology programs are often found in academic medical centers, but that does not mean that community oncology settings cannot establish something similar as well, says Janine Overcash, PhD, associate professor of clinical nursing and director of the Adult/Geriatric Nurse Practitioner Program at The Ohio State University.

Nadine Barrett, Ph.D., director of the Office of Health Equity and Disparities at the Duke Cancer Institute, discusses the importance of creating meaningful community partnerships that can improve health outcomes.

Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.

Sandra Ruland, RN, OCN, says she has to strike a delicate balance when talking to patients about how they use the internet to research their cancer.

Kerry Nichols, RN, BSN, OCN, explains their nurse navigator-led smoking cessation program.

Dawn Frambes, PhD, RN, discusses the importance of involving the caregivers (and other friends and family) in the delivery of treatments for symptom management.

Megan Hoffman, MSN, RN, CMSRN, AOCNS, discusses the importance of nurse's understanding genomics so their patients can get the full benefit.